Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1995-06-06
1996-05-21
Hollinden, Gary E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
A61K 31135
Patent
active
055190618
ABSTRACT:
The subject invention provides R(+)-N-propargyl-1-aminoindan and pharmaceutically acceptable salts thereof, as well as pharmaceutical compositions containing same. The subject invention also provides methods of treating a subject afflicted with Parkinson's disease, a memory disorder, dementia, depression, hyperactive syndrome, an affective illness, a neurodegenerative disease, a neurotoxic injury, brain ischemia, a head trauma injury, a spinal trauma injury, schizophrenia, an attention deficit disorder, multiple sclerosis, or withdrawal symptoms, using R(+)-N-propargyl-1-aminoindan or the pharmaceutically acceptable salt of the subject invention. The subject invention further provides a method of preventing nerve damage in a subject. Finally, the subject invention provides methods of preparing R(+)-N-propargyl-1-aminoindan, a salt thereof, and racemic N-propargyl-1-aminoindan.
REFERENCES:
patent: 3201470 (1965-08-01), Huebner
patent: 3253037 (1966-05-01), Huebner
patent: 3513244 (1970-05-01), Giltos et al.
patent: 4826875 (1989-05-01), Chiesi
Brit. J. Pharm. 85:541-6 (1985).
The Merck Index, Tenth Ed. pp. 149, 248-249 (1983).
Finberg and Youdim, British J. Pharmac. (Jun. 1985) 85(2):541-546.
Kabins and Gershon, Dementia (1990) 1:323-348.
The Merck Index (Tenth ed. 1983) pp. 149, 248-249.
The Parkinson Study Group, New England J. Med. (1989) 321(20):1364-1371.
The Parkinson Study Group, New England J. Med. (Jan. 21, 1993) 328(3):176-183.
Riederer and Youdim, J. Neurochem. (1986) 46(5):1359-1365.
Tekes, et al., Pol. J. Pharmacol. Pharm. (1988) 40:653-658.
Youdim, et al., in Handbook of Experimental Pharmacology vol. 90/I (1988) Chapter 3, Trendelenburg and Weiner, eds.
Finberg John P. M.
Levy Ruth
Yellin Haim
Youdim Moussa B. H.
Burn Brian M.
Hollinden Gary E.
Technion Research and Development Foundation Ltd.
Teva Pharmaceutical Industries Ltd.
White John P.
LandOfFree
R-enantiomer of n-propargyl-1-aminoindan, salts, compositions an does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with R-enantiomer of n-propargyl-1-aminoindan, salts, compositions an, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and R-enantiomer of n-propargyl-1-aminoindan, salts, compositions an will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2038426